AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Transgenic Mouse Model of Amyloid Pathogenesis

Technology Benefits
First in vivo system for testing the contribution of stress to AD
Detailed Technology Description
Mouse model for directly testing the involvement of stress in Alzheimer's disease progress #CNS #Alzheimer'sdisease #researchtool #animalmodel
*Abstract

Northwestern researchers have engineered a triple transgenic mouse that can be used to investigate the contribution of stress to development of Alzheimer's Disease (AD). The more common, sporadic form of AD is not well understood and is thought to arise through a combination of genetic and environmental factors. Psychological stress is one of the environmental factors thought to contribute to AD; however, the methods available for studying this phenomenon are limited to in vitro systems. This novel transgenic mouse model from Prof. Csernansky's group could allow researchers to get a granular view of the contribution of stress to the pathogenic process in vivo for the first time. In the future, this transgenic mouse model may also be used to identify aberrant signaling processes that can be targeted in order to slow down or completely halt progress of Alzheimer's disease.

*Inventors
John Csernansky* Hongxin Dong Louis Muglia
*Publications
Dong H, Murphy KM, Meng L, Montalvo-Ortiz J, Zeng Z, Kolber BJ, Zhang S, Muglia LJ, Csernansky JG (2012) Corticotropin Releasing Factor Accelerates Neuropathy and Cognitive Decline in a Mouse Model of Alzheimer's Disease, J Alzheimers Dis, 28: 579-92.
Country/Region
USA

For more information, please click Here
Mobile Device